Defence Therapeutics Expands Radiopharmaceutical Development Strategy with Alpha and Beta-Emitter Programs

Go back to Defence Therapeutics Expands Radiopharmaceutical Development Strategy with Alpha and Beta-Emitter Programs
(AMEX: DTCFF) Delayed: 0.25 --0 (-0%)
Previous Close $0.25    52 Week High $ 
Open $0.26    52 Week Low $ 
Day High $0.26    P/E N/A 
Day Low $0.24    EPS $ 
Volume 90,650